Merck CEO to be deposed in Vioxx suits
115220
BOSTON (CBS.MW) - A New Jersey state court has ruled that plaintiffs&#39; attorneys can depose Merck &amp; Co. chairman and chief executive officer Raymond Gilmartin in preparation for their lawsuits against the company over its recalled drug Vioxx.
119463
Jeffrey Greenberg, the chief executive of Marsh &amp; McLennan, the insurance broker accused of rigging the market to make inappropriate fees from customers, was yesterday expected
174702
Hundreds of plaintiffs&#39; lawyers who say that people in the United States have been injured or killed by the painkiller Vioxx plan to meet in the coming week to lay groundwork for a nationwide legal drive against the drug&#39;s maker, Merck.
183171
EDINBURG - A South Texas woman has sued drug maker Merck &amp; Co., alleging that she had to have heart surgery after using the arthritis drug Vioxx.
182593
In a hearing before the Senate Finance Committee, the chairman and chief executive of Merck & Company was treated gently, in spite of bad news about Vioxx.
700323
TRENTON -- Lawyers defending plaintiffs alleging theyâve been injured or have had loved ones die because of ingesting Vioxx are meeting this week to possibly plan a coordinated nationwide legal assault against the pharmaceutical giant Merck.
659314
A Brooklyn lawyer announced plans yesterday to file the first federal lawsuits against Merck &amp; Co. on behalf of New Yorkers who developed heart troubles using the arthritis drug Vioxx.
9199
Merck &amp; Co. Inc. has been in crisis since Sept. 30, when the company pulled its prescription painkiller Vioxx off the market after a study confirmed the drug increased the risk of heart attack and stroke. Merck chief Raymond Gilmar tin is grappling with multiple product-liability and shareholder lawsuits. Scheduled to retire in April 2006 under a plan in place ...
515664
Pharmaceutical giant Merck &amp; Co., under siege over revenues lost since it recalled arthritis drug Vioxx, will have cut about 5,100 jobs by year&#39;s end, 700 more than first planned, and will slash costs by $2.4 billion over four years, chairman and CEO
562151
Federal prosecutors and the Securities and Exchange Commission are investigating Merck &amp; Co. in connection with Vioxx, the painkiller that was pulled from the market in September
497832
A former executive at the Gaithersburg biotechnology firm MedImmune Inc. is scheduled to plead guilty today to criminal charges related to his allegedly improper stock trades, according to court papers.
390243
People taking Vioxx may feel betrayed now that the popular painkiller and arthritis medicine has been pulled from the market. Merck, the manufacturer of the drug, and the US Food and Drug Administration knew
156669
Drugs giant Merck & Co. which pulled  its blockbuster painkiller Vioxx from shelves in September, is  about to become the target of hundreds of plaintiffs' lawyers,  the New York Times reported on Friday.
685306
Merck &amp; Co. Inc. (MRK.N: Quote, Profile, Research) , reeling from the recent withdrawal of its Vioxx arthritis drug, on Wednesday said 2005 earnings will decline to
279051
Hundreds of plaintiffsâ lawyers who claim that people were injured or killed by the painkiller Vioxx, plan to meet next week to lay the groundwork for a nationwide legal assault against the drugâs maker, Merck.
453249
Law &amp; Order: Pharmaceutical Unit. Merck (nyse: MRK - news - people ) Chief Executive Raymond V. Gilmartin may testify in some of the many lawsuits filed over the Vioxx recall, a company lawyer said.
97341
The withdrawal of painkiller Vioxx means Merck &amp; Co. will miss the already diminished expectations of Wall Street analysts for 2005, the huge drug maker said Wednesday.